STRATEGY & CONSULTING

Peregrine Market Access specializes in addressing your brand’s specific needs across the product life cycle.

Our strategy and consulting services span a wide spectrum:

• Commercialization, including organization design, franchise and product maximization, pricing, and market access

• Clinical development and medical affairs

• Education and training

• Sales analytics

We ground our work in a clear understanding of the market and disease state to uncover key findings and implications that inform the development of a sound access strategy.

We help our clients do the right thinking up front

Landscape assessment

Proper situation analysis and landscape assessment are the first steps toward understanding unmet needs in a therapeutic class as well as the strengths and weaknesses of available treatment options. This foundational exploration enables the Peregrine team to deliver a differentiated and impactful brand story.

We meticulously evaluate available market data and information to assess payer coverage, distribution challenges, benefit design, and other important variables. We delve deep into the drivers and barriers so we can clearly see your brand through the eyes of your potential customers.

We’ll help your team establish a clearly differentiated position in the market, so payers and other market access customers understand the clinical and cost benefits of your brand.

Value proposition development

A strong value proposition is essential for effectively communicating the clinical benefit and cost impact of a treatment, device, or diagnostic.

When developing value messages, we address the key factors that payers consider before making a decision:

• Unmet need

• Clinical benefit

• Cost impact

• Data modeling

Our message platform is grounded in specific strategies and has compelling and customized messaging that dials up the value drivers that resonate with each target customer. Additionally, the messaging anticipates and proactively addresses potential objections or concerns that each stakeholder group may have about the treatment.

By clearly identifying the product’s unique benefits and value, we aid our clients in securing positive coverage and market success.

Access product launch strategy

Understanding the different components that factor into a product launch is a formidable task. Peregrine Market Access can simplify the intricacies of a launch strategy and guide you every step of the way. We are adept at analyzing the market, developing an access-focused launch blueprint tailored to your brant’s needs, and seamlessly executing numerous work streams, efficiently and effectively.

Key components of launch readiness typically include:

• Landscape assessment

• Customer segmentation and targeting

• Omnichannel communications strategy

• Value proposition and message development

The experienced team at Peregrine Market Access can train your account managers on each part of the launch plan to ensure understanding. Plus, we’re always available as a launch resource, including our Contract Account and Sales Team, to help elevate your organization as a whole.

FDAMA 114 consulting

As the payer conversation shifts from cost to value, manufacturers have to figure out how to explain the value proposition for the brand in terms that will resonate with all stakeholders in the formulary decision-making process. The Food and Drug Modernization Act of 1997, Section 114 (FDAMA 114) is the guiding document for leading those conversations in a legal and compliant way.

Peregrine Market Access was a pioneer in creating FDAMA 114 messaging. We understand how to use this legal clause to help inform and influence key decision-makers.

Our team knows that determining the value of a product requires demonstrating how the clinical benefit impacts the overall healthcare cost of both the patient and the member population to which the patient belongs.

There are 4 areas to focus on when investigating the cost impact of a therapeutic intervention:

• Acquisition cost

• Dosing variability

• Cost per consequence avoided

• Cost per outcome achieved

Peregrine Market Access can help you analyze your data, working alongside your clinical specialists and health economists. Alternatively, if a company needs more support, we can do that work ourselves, all while helping you to better understand what your brand can achieve.

Strategies for favorable market access

When it comes to an effective access and reimbursement strategy, Peregrine Market Access leverages its data and communications expertise to drive positive access for a treatment and success for the brand.